
AFRM (Affirm) Stock Analysis: Hold at $49 | $65 Target
April 9, 2026 · Spicer Matthews
AFRM rated Hold with $65 target (+33%). First-ever GAAP profit, 30% revenue growth, but zero insider buys across 85 transactions. 8-week base forming.

April 9, 2026 · Spicer Matthews
AFRM rated Hold with $65 target (+33%). First-ever GAAP profit, 30% revenue growth, but zero insider buys across 85 transactions. 8-week base forming.

April 8, 2026 · Spicer Matthews
META rated Buy with $750 target (+22.5%). $201B revenue +22%, FoA 51.6% margin, $46B FCF, PEG 0.91. Bill Ackman buying. CFO sold $88M Feb.

March 31, 2026 · Spicer Matthews
AMZN rated Hold with $240 target (+15%). $717B revenue growing 12%, AWS +20%, but $128B AI capex collapsed FCF 71%. Wait for Q1 earnings clarity.

March 22, 2026 · Spicer Matthews
ALK rated Buy with $55 target (+52%). Crashed 54% on Iran/oil panic. 6.7x adj P/E, 0.7x P/B, $5.40 adjusted EPS. Hawaiian synergies coming.

March 22, 2026 · Spicer Matthews
DIS rated Buy with $120 target (+21%). 14.5x P/E, $18B OCF, parks +6% growth. Director Gorman buying $4.1M personally. CEO transition risk.

March 16, 2026 · Spicer Matthews
IONQ rated Hold with $34 target (+3%). Revenue tripled to $130M but 93x P/S, negative margins, and $335M coordinated insider selling.

March 16, 2026 · Spicer Matthews
RIVN rated Hold with $16 target (+8%). First gross profit year, R2 launching Q2 2026, but execution risk and cash burn remain concerns.

March 16, 2026 · Spicer Matthews
SMMT rated Speculative Hold. Binary FDA bet on ivonescimab — bull case $28-35, bear case $3-5. PDUFA Nov 14, 2026.

March 16, 2026 · Spicer Matthews
TMO rated Buy with $575 target (+22%). Forward P/E 17.5x cheapest since March 2020. $6.3B FCF, Life Sciences recovery, RSI deeply oversold at 28.

March 15, 2026 · Spicer Matthews
BE is a HOLD at $154.51. AI data center power thesis is real, but 21x P/S and lopsided insider selling mean risk/reward is unfavorable.

March 15, 2026 · Spicer Matthews
BROS rated Buy with $68 target (+44% upside). 28% revenue growth, transaction-driven comps, and a 4,000+ store runway offset insider selling headwinds.

March 15, 2026 · Spicer Matthews
GTLB rated Hold with $32 target (+41% upside). Extraordinary fundamental value offset by devastating technicals and relentless insider selling.

March 15, 2026 · Spicer Matthews
SNDK rated Hold with $550 target (-17%). NAND supercycle leader with 50.9% gross margins, priced for perfection. Wait for $400-450 entry.

March 15, 2026 · Spicer Matthews
STX rated Buy with $475 target (+24% upside). HAMR technology moat and AI storage demand drive the thesis, offset by balance sheet leverage.

March 15, 2026 · Spicer Matthews
TOST rated Buy with $38 target (+38% upside). PEG of 0.66, fortress balance sheet, and dominant restaurant platform drive the thesis.